Issued Patents All Time
Showing 25 most recent of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12359002 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2025-07-15 |
| 12152076 | Bispecific and monospecific antibodies using novel anti-PD-1 sequences | Matthew Bernett, Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon +1 more | 2024-11-26 |
| 12129309 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid | 2024-10-29 |
| 11945880 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2024-04-02 |
| 11859011 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2024-01-02 |
| 11673972 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2023-06-13 |
| 11492407 | Bispecific checkpoint inhibitor antibodies | Matthew Bernett, Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon +1 more | 2022-11-08 |
| 11472890 | Heterodimeric antibodies that bind ENPP3 and CD3 | Rumana Rashid, Gregory Moore, Alex Nisthal, Seung Chu, Sung-Hyung Lee +1 more | 2022-10-18 |
| 11352442 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid | 2022-06-07 |
| 11312770 | Bispecific and monospecific antibodies using novel anti-PD-1 sequences | Matthew Bernett, Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon +1 more | 2022-04-26 |
| 11225528 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2022-01-18 |
| 11111315 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2021-09-07 |
| 10913803 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2021-02-09 |
| 10889653 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2021-01-12 |
| 10752678 | Complement component C5 antibodies | Peter C. Baciu, Yanbin Liang, Jason Guu, Matthew Bernett, John Desjarlais | 2020-08-25 |
| 10526417 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid | 2020-01-07 |
| 10259887 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2019-04-16 |
| 9932395 | Nucleic acids encoding complement component C5 antibodies | Peter C. Baciu, Yanbin Liang, Jason Guu, Matthew Bernett, John Desjarlais | 2018-04-03 |
| 9856327 | Heterodimeric antibodies to CD3 X CD123 | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2018-01-02 |
| 9850320 | Heterodimeric antibodies to CD3 X CD20 | Matthew Bernett, Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid +1 more | 2017-12-26 |
| 9701743 | Complement component C5 antibodies | Peter C. Baciu, Yanbin Liang, Jason Guu, Matthew Bernett, John Desjarlais | 2017-07-11 |
| 9040042 | Optimized antibodies that target HM1.24 | Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Duc-Hanh Thi Nguyen +1 more | 2015-05-26 |
| 8394374 | Optimized antibodies that target HM1.24 | Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Duc-Hanh Thi Nguyen +1 more | 2013-03-12 |
| 7244823 | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders | Bassil Dahiyat, John Desjarlais, Anton Filikov, Malu Tansey, Jonathan Zalevsky | 2007-07-17 |
| 7144987 | Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders | Arthur J. Chirino, Peizhi Luo, Peter Colon McDonnell, Malu Tansey | 2006-12-05 |